Genscript Biotech Corp Class H 01548
Trading Information
- Previous Close Price
- HKD 10.08
- Day Range
- HKD 9.96–10.54
- 52-Week Range
- HKD 9.96–24.95
- Bid/Ask
- HKD 9.99 / HKD 10.00
- Market Cap
- HKD 21.26 Bil
- Volume/Avg
- 20.1 Mil / 14.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.24
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
GenScript Biotech is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. The company estimates that more than two-thirds of GenScript’s valuation is from its ownership stake in Legend.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 6,937
- Website
- https://www.genscript.com
Comparables
Valuation
|
Metric
|
01548
|
01244
|
APLM
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.12 | 1.68 | 1.49 |
Price/Sales | 3.24 | 2.18 | — |
Price/Cash Flow | — | — | — |
Price/Earnings
01548
01244
APLM
Financial Strength
|
Metric
|
01548
|
01244
|
APLM
|
|---|---|---|---|
Quick Ratio | 5.37 | 2.16 | 2.82 |
Current Ratio | 5.64 | 2.19 | 2.95 |
Interest Coverage | −20.46 | −72.21 | −1,154.63 |
Quick Ratio
01548
01244
APLM
Profitability
|
Metric
|
01548
|
01244
|
APLM
|
|---|---|---|---|
Return on Assets (Normalized) | −9.60% | −19.25% | −123.31% |
Return on Equity (Normalized) | −25.81% | −28.69% | — |
Return on Invested Capital (Normalized) | −15.54% | −23.70% | — |
Return on Assets
01548
01244
APLM
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ffjqvyztz | Bsmk | $590.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Dclydsgv | Xztldg | $113.8 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Wbdgtysy | Qzrlz | $108.0 Bil | |
MRNA
| Moderna Inc | Tjzsvhw | Jvx | $54.6 Bil | |
BNTX
| BioNTech SE ADR | Xblbdqdn | Bsyl | $24.2 Bil | |
ARGX
| argenx SE ADR | Gthbrwgwn | Lxt | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Wlqpgmmb | Hbklq | $18.8 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Vgcfrrhd | Jyyltz | $14.3 Bil | |
INCY
| Incyte Corp | Ytbskbfr | Kdcgn | $13.0 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fjgfdcsjw | Ljdktf | $12.4 Bil |